Mortality

BOSTON — Patients with both COPD and type 2 diabetes who used GLP-1 agonists or co-agonists had improved respiratory outcomes vs. those who used other type 2 diabetes medications, according to data presented at the CHEST Annual Meeting.

BOSTON — Fewer patients with pulmonary arterial hypertension died at three time points with use of a sodium-glucose cotransporter-2 inhibitor, according to data presented at the CHEST Annual Meeting.

The ketogenic diet could reduce the risk for all-cause mortality by up to 24%, an analysis published in Scientific Reports showed.

The rates of melanoma incidence have significantly declined since approximately 2015 in patients aged younger than 50 years while mortality also dropped in those aged younger than 60, according to a Swedish study.

BOSTON — Having a COPD exacerbation hospitalization in combination with COVID-19 vs. no COVID-19 significantly raised the odds for mortality and invasive ventilation, according to a poster presented at the CHEST Annual Meeting.

BOSTON — Women with COPD who live in rural areas have poorer Environmental Justice Index scores indicating disparities than those who live in urban areas, according to a study presented at the CHEST Annual Meeting.

BOSTON — During COVID-19 hospitalization, patients faced lower odds for mortality and respiratory failure with vs. without documented cannabis use, according to data presented at the CHEST Annual Meeting.

Presented results showed patients with odontoid fractures experienced significantly higher mortality risks 2 and 4 years after initial injury compared with patients with hip fractures.

There may be a nonlinear connection between platelet count and 30-day in-hospital mortality in patients with end-stage kidney disease in the ICU, according to researchers.

BOSTON — The odds for mortality, ventilation and septic shock among adults hospitalized with COPD went down if they also had GERD, according to data presented at the CHEST Annual Meeting.